Market Place
Sourcing Support
Acura Pharmaceuticals and AD Pharma Amend License to LIMITx LTX-03
01 Mar 2022 //
GLOBENEWSWIRE
Acura Pharmaceuticals Provides Development Update on LTX-03
14 Feb 2022 //
GLOBENEWSWIRE
Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results
16 Aug 2021 //
GLOBENEWSWIRE
Acura Pharmaceuticals and AD Pharma Amend License to LIMITxâ„¢ LTX-03
26 Jul 2021 //
GLOBENEWSWIRE
Acura Pharmaceuticals Provides Development Update on LTX-03
07 Jun 2021 //
GLOBENEWSWIRE
Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03
28 Oct 2020 //
GLOBENEWSWIRE
Acura Pharmaceuticals Provides an Update on the Development of LTX-03
23 Mar 2020 //
GLOBENEWSWIRE
Acura Pharmaceuticals Provides an Update on the Development of LTX-03
02 Jan 2020 //
GLOBENEWSWIRE
Catalent, Acura Enter Clinical Manufacturing Pact
16 Sep 2019 //
CONTRACTPHARMA
Bayer ends methamphetamine abuse deterrent partnership with Acura
07 Jul 2017 //
IN PHARMATECHNOLOGIST
Acura Pharmaceuticals Exploring Strategic Alternatives
04 Jan 2017 //
GLOBENEWSWIRE
Acura Pharmaceutical Provides Development Update on its LIMITx(TM) Technology
14 Dec 2016 //
EINNEWS
Egalet`s pain management therapy, Oxaydo receives US patent
21 Nov 2016 //
PHARMABIZ
Kempharm opts for Acura`s anti-abuse tech in $3.5m deal
20 Oct 2016 //
IN PHARMATECHNOLOGIST
UPDATE 1-Collegium`s painkiller gets green light from FDA panel
12 Sep 2015 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.